DK0578511T3 - Spirooxathiolan-quinuclidinderivat til behandling af Sjögrens syndrom - Google Patents

Spirooxathiolan-quinuclidinderivat til behandling af Sjögrens syndrom

Info

Publication number
DK0578511T3
DK0578511T3 DK93305423T DK93305423T DK0578511T3 DK 0578511 T3 DK0578511 T3 DK 0578511T3 DK 93305423 T DK93305423 T DK 93305423T DK 93305423 T DK93305423 T DK 93305423T DK 0578511 T3 DK0578511 T3 DK 0578511T3
Authority
DK
Denmark
Prior art keywords
spirooxathiolan
sjögren
syndrome
treatment
quinuclidine
Prior art date
Application number
DK93305423T
Other languages
Danish (da)
English (en)
Inventor
Nobuaki Abe
Yasuyoshi Takeshita
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16540522&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0578511(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Application granted granted Critical
Publication of DK0578511T3 publication Critical patent/DK0578511T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK93305423T 1992-07-10 1993-07-09 Spirooxathiolan-quinuclidinderivat til behandling af Sjögrens syndrom DK0578511T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4207485A JP2683783B2 (ja) 1992-07-10 1992-07-10 シェーグレン症候群治療剤

Publications (1)

Publication Number Publication Date
DK0578511T3 true DK0578511T3 (da) 2000-04-03

Family

ID=16540522

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93305423T DK0578511T3 (da) 1992-07-10 1993-07-09 Spirooxathiolan-quinuclidinderivat til behandling af Sjögrens syndrom

Country Status (15)

Country Link
US (1) US5340821A (de)
EP (1) EP0578511B1 (de)
JP (1) JP2683783B2 (de)
KR (1) KR100331046B1 (de)
AT (1) ATE184483T1 (de)
AU (1) AU666734B2 (de)
CA (1) CA2099970C (de)
DE (1) DE69326395T2 (de)
DK (1) DK0578511T3 (de)
ES (1) ES2138613T3 (de)
IL (1) IL106218A (de)
NO (1) NO303765B1 (de)
NZ (1) NZ248099A (de)
TW (1) TW230750B (de)
ZA (1) ZA934883B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2852608B2 (ja) * 1994-06-27 1999-02-03 雪印乳業株式会社 口腔乾燥症治療剤
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
JP4447685B2 (ja) * 1999-01-14 2010-04-07 第一三共株式会社 皮膚乾燥症治療剤
JP2006070027A (ja) * 2004-08-06 2006-03-16 Dai Ichi Seiyaku Co Ltd 口腔粘膜投与剤
US20110150974A1 (en) * 2004-08-06 2011-06-23 Daiichi Pharmaceutical Co., Ltd. Agent For Oral Mucosal Administration
WO2006038596A1 (ja) * 2004-10-05 2006-04-13 Astellas Pharma Inc. 涙液及び唾液乾燥症治療用医薬組成物
EP2258358A3 (de) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenese mit Acetylcholinesterasehemmer
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP1940389A2 (de) 2005-10-21 2008-07-09 Braincells, Inc. Modulation von neurogenese durch pde-hemmung
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
CA2651813A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2026813A2 (de) 2006-05-09 2009-02-25 Braincells, Inc. 5-ht-rezeptor-vermittelte neurogenese
EP2068872A1 (de) 2006-09-08 2009-06-17 Braincells, Inc. Kombinationen mit einem 4-acylaminopyridin-derivat
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US8143400B2 (en) * 2008-01-10 2012-03-27 Apotex Pharmachem Inc. Process for the preparation and purification of cis-2-methylspiro(1,3-oxathiolane-5,3′)quiniclidine hydrochloride
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
DK2498771T3 (da) 2009-11-12 2014-01-27 Acacia Pharma Ltd Anvendelse af bethanechol til behandling af xerostomi
GB201107533D0 (en) 2011-05-06 2011-06-22 Acacia Pharma Ltd Formulaiton
CN102846607A (zh) * 2012-04-09 2013-01-02 珠海亿邦制药股份有限公司 一种以盐酸西维美林为活性成分的固体制剂及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001396A (en) * 1971-08-04 1977-01-04 Chinoin Pharmaceutical And Chemical Works Ltd. Hormonal product extracted from parathyroid gland and process for the preparation thereof
US4110441A (en) * 1974-04-29 1978-08-29 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. Gamma-l-glutamyl cholamine phosphate
US4100271A (en) * 1976-02-26 1978-07-11 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
US4855290A (en) * 1985-05-10 1989-08-08 State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research Derivatives of quinuclidine
US4684727A (en) * 1985-07-29 1987-08-04 Schering Corporation Zwitterionic 1,8-naphthyridine and pyrazino[2,3-b]pyridine containing compounds useful as anti-allergic, anti-inflammatory and cycloprotective agents
ZA868369B (en) * 1986-01-10 1987-11-25 Israel State Derivatives of quinuclidine
GB8717446D0 (en) * 1987-07-23 1987-08-26 Merck Sharp & Dohme Chemical compounds
US4876260A (en) * 1987-10-28 1989-10-24 State Of Israel, Israel Institute Of Biological Research Oxathiolanes
CA1303503C (en) * 1987-11-10 1992-06-16 Marc Plamondon Ophthalmic solution comprising iodine-polyvinylpyrrolidone complex
MX18467A (es) * 1988-11-23 1993-07-01 Pfizer Agentes terapeuticos de quinuclidinas
US4997654A (en) * 1989-08-14 1991-03-05 Warner-Lambert Company Method for increasing salivation for xerostomia patients
US5242930A (en) * 1991-02-11 1993-09-07 Merck Sharp & Dohme Ltd. Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy

Also Published As

Publication number Publication date
EP0578511B1 (de) 1999-09-15
US5340821A (en) 1994-08-23
KR100331046B1 (ko) 2002-08-19
IL106218A0 (en) 1993-11-15
ES2138613T3 (es) 2000-01-16
DE69326395D1 (de) 1999-10-21
TW230750B (de) 1994-09-21
NO932520D0 (no) 1993-07-09
KR940005274A (ko) 1994-03-21
ZA934883B (en) 1994-02-03
CA2099970A1 (en) 1994-01-11
NZ248099A (en) 1999-07-29
AU666734B2 (en) 1996-02-22
EP0578511A1 (de) 1994-01-12
AU4181993A (en) 1994-01-13
NO303765B1 (no) 1998-08-31
IL106218A (en) 1997-02-18
CA2099970C (en) 2003-12-30
NO932520L (no) 1994-01-11
JPH0624981A (ja) 1994-02-01
DE69326395T2 (de) 2000-04-20
ATE184483T1 (de) 1999-10-15
JP2683783B2 (ja) 1997-12-03

Similar Documents

Publication Publication Date Title
DK0578511T3 (da) Spirooxathiolan-quinuclidinderivat til behandling af Sjögrens syndrom
ATE117685T1 (de) Chinoloncarbonsäure-derivate.
NL300407I1 (nl) Difluoroprostaglandinederivaten en hun toepassing
DK0493608T3 (da) Quinoloncarboxylsyrederivat
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
DK1063228T3 (da) Cycloalkenderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf
ATE74608T1 (de) Chinolincarbonsaeure-derivate.
ES2115600T3 (es) Derivados de 1-metilcarbapenem y procedimiento para su preparacion.
ES2192584T3 (es) Derivado pirimidinilpirazol.
DK0508740T3 (da) Thiazolidindionderivater, deres fremstilling og anvendelse.
ES2038710T3 (es) Un procedimiento de preparacion de un derivado de benzoxazina y su utilizacion.
NO173991C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater
DE69208400D1 (de) Mono- und Bis-Alkylaminoanthracycline
DE69123757D1 (de) Epoxysuccinamidsäurederivat
DE69001004D1 (de) Zusammensetzung gegen leberkrankheiten.
DK360388D0 (da) Laegemiddel til behandling af hjerteinsufficiens
DE69411852D1 (de) Indolderivate, ihre Salze und sie enthaltende Arzneimittel zur Behandlung von Herzkrankheiten
DK0551844T3 (da) Svovlholdige galdesyrederivater
ATE95697T1 (de) Uricosuretische zusammensetzung.
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
ATE189813T1 (de) Prostaglandin-i-analoga
DE69424677D1 (de) Präparat zur behandlung der drogenabhängigkeit